๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

MYCN as a target for cancer immunotherapy

โœ Scribed by Nourredine Himoudi; Mengyong Yan; Antigoni Papanastasiou; John Anderson

Publisher
Springer-Verlag
Year
2007
Tongue
English
Weight
438 KB
Volume
57
Category
Article
ISSN
0340-7004

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gangliosides as targets for immunotherap
Gangliosides as targets for immunotherapy for pancreatic adenocarcinoma
โœ Kyo U. Chu; Mepur H. Ravindranath; Alexandra Gonzales; Kevin Nishimoto; Wai Yin ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 143 KB

## Background: Pancreatic adenocarcinoma cells express gangliosides and sialyl lewis (sle) antigens. it is not known whether these carbohydrate antigens can be targeted by immunotherapy. the authors measured the expression of gm(2) and sle antigens on the surface of pancreatic carcinoma cells and t

Immunotoxins as tools for cancer immunot
Immunotoxins as tools for cancer immunotherapy
โœ H.E. Blythman; F.K. Janser; P. Casellas; O. Gross; H. Vidal ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 81 KB
The forkhead box M1 transcription factor
The forkhead box M1 transcription factor as a candidate of target for anti-cancer immunotherapy
โœ Kazunori Yokomine; Satoru Senju; Tetsuya Nakatsura; Atsushi Irie; Yuki Hayashida ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 509 KB

## Abstract The present study attempted to identify a target antigen for immunotherapy for cholangiocarcinoma. Forkhead box M1 (FOXM1) was selected as a candidate antigen based on the data of previous cDNA microarray analysis of clinical samples of cholangiocarcinoma. The level of __FOXM1__ mRNA wa